Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8242492 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 9 Pages |
Abstract
In advanced NSCLC patients treated with chemoradiation, IMRT resulted in significantly lower levels of Grade â¥3 TRP compared with 3D-CRT. Clinical, dosimetric, and patient selection factors that may have influenced rates of TRP require continuing investigation. A randomized trial comparing IMRT with 3D-CRT has been initiated.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sue S. M.D., Ph.D., Zhongxing M.D., H. Helen Ph.D., Susan L. Ph.D., Chao-Su M.D., Xiong M.D., Xuanming Ph.D., Shulian M.D., Radhe Ph.D., James D. M.D., Ritsuko M.D.,